January 14, 2022
USP extends BUD comment deadline
Today we learned that USP has extended the comment period for its proposed changes to chapters <795> and <797>.
APC, APhA, and NCPA sent a joint letter to USP in December asking for the comment period to be extended through the end of April. USP has agreed to extend it through March 17.
We welcome this extension, and we thank USP for granting it. We’ll use this additional time to continue to educate compounders and prescribers about the potential impact these proposed BUDs would have on their patients.
Speaking of which, please remember that APC is holding a 30-minute briefing for prescribers this coming Thursday, January 20, to educate them about the complications such BUDs could bring to patient care. Please let the prescribers you work with know about this briefing — we need to get the word out quickly. Thank you!
